ARK Diagnostics, Inc. received 510(k) clearance from FDA for the ARK Tramadol Assay.

December 2018

ARK Diagnostics, Inc. received 510(k) clearance from FDA for the ARK EDDP Assay.

November 2018

IATDMCT

Brisbane, Australia - September 16-18 2018

TIAFT

Ghent, Belgium - August 26-30 2018

AACC

Chicago, IL - July 29-August 2 2018

ARK Diagnostics, Inc. received 510(k) clearance from FDA for the ARK Fentanyl Assay.

June 2018

American Transplant Congress (ATC)

Seattle, WA - June 2-6 2018

CAT

Sonoma County, CA - May 7-8 2018

MATT

Indianapolis, IN - April 12-13 2018

TIAFT/SOFT

Boca Roton, FL - January 6-12 2018

IATDMCT

Kyoto, Japan - September 24-27 2017

AACC

San Diego, CA - July 30-August 3 2017

ASM/ICAAC - Voriconazole

New Orleans, LA - June 1-5 2017

EuroMedlab

Athens, Greece - June 11-15 2017

FDA de novo granted for the ARK Voriconazole II Assay.

May 2017

AES

Houston, TX - December 02-06 2016

SOFT

Dallas, TX - October 16-21 2016

ARK Diagnostics, Inc. received 510(k) clearance from FDA for the ARK Oxcarbazepine Metabolite Assay.

August 2016

TIAFT

Brisbane, Australia - August 28-September 2016

AACC

Philadelphia, Pennsylvania - July 31-August 4

21st International AIDS Conference

Durban, South Africa - July 17-22 2016

AAFS - American Academy of Forensic Sciences

Las Vegas, Nevada - February 22-27 2016